United States · FDA National Drug Code directory
OCTREOTIDE ACETATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67457-762_49d0f367-0a1c-40e4-8732-f0c9ce935a44
- Product NDC
- 67457-762
- Form
- KIT
- Composition / generic term
- OCTREOTIDE ACETATE
- Labeler
- Mylan Institutional LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260128
- Source listing expiry
- 20271231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 KIT (67457-762-30) * 6 mL in 1 VIAL (67457-760-30) * 2 mL in 1 SYRINGE (67457-761-02) · 67457-762-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →